Dr. Eun Jung Lee stated, “We are about to complete the optimization of the PROX1-neutralizing antibody (CLZ001) and move to preclinical studies before ... and the Korea Drug Development Foundation ...

In this interview, rare disease expert Oxana Iliach discusses challenges with rare disease drug development and how they can ...

Accomplished immunologist brings 15 years of experience in preclinical development, translational biology and drug discovery SOUTH KINGSTON, R.I., April 17, 2025--(BUSINESS WIRE)--MindImmune ...

Biotech companies developing drugs for hard-to-treat diseases and other ailments are being forced to push back clinical trials and drug testing in the wake of mass layoffs at the Food and Drug ...

Introducing our In Focus on organ-on-a-chip (OoC) technology in drug development, this video explores what OoCs are, how they work and how they can be used in drug development to reduce the number of ...

"C-Path was built on the vision that no single entity can solve the challenges of the drug development process alone," said former C-Path CEO Dr. Woosley. "Over the last 20 years, C-Path has ...

This milestone strengthens the company's FDA Orphan Drug Application and positions Exousia Pro to become a leader in innovative cancer treatments. Nearly 90% of glioblastoma preclinical studies ...

Zymeworks presents six posters at AACR highlighting advancements in antibody-drug conjugates ... of six posters with new preclinical data from its preclinical, development-stage, and clinical ...